Protara Therapeutics Stock Forecast

Hold candidate since Jul 31, 2026

The Protara Therapeutics, Inc. stock price fell by -2.73% on the last day (Friday, 31st Jul 2026) from $4.03 to $3.92. During the last trading day the stock fluctuated 5.12% from a day low at $3.81 to a day high of $4.00. The price has fallen in 7 of the last 10 days and is down by -4.39% for this period. Volume has increased on the last day by 26 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 293 thousand shares were bought and sold for approximately $1.15 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -23.78% during the next 3 months and, with a 90% probability hold a price between $2.21 and $3.31 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

TARA Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 11, 2026, and so far it has risen 7.40%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Protara Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.97 and $4.04. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Protara Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Protara Therapeutics, Inc. stock

Protara Therapeutics, Inc. finds support from accumulated volume at $3.82 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.195 between high and low, or 5.12%. For the last week, the stock has had daily average volatility of 4.77%.

Our recommended stop-loss: $3.79 (-3.30%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 34 days ago.)

Trading Expectations (TARA) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Protara Therapeutics, Inc. to open at $3.91, and during the day (based on 14 day Average True Range), to move between $3.82 and $4.02, which gives a possible trading interval of +/-$0.193 (+/-5.04%) up or down from last closing price. If Protara Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.82 (2.55%) than the resistance at $4.04 (3.06%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Protara Therapeutics, Inc. stock A Buy?

Protara Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.370 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $3.91 ( 0.298%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk